BridgeBio Pharma, Inc. (BBIO) vs Blueprint Medicines Corporation (BPMC)
Detailed comparison between BridgeBio Pharma, Inc., Blueprint Medicines Corporation.Total Return (%)
BridgeBio Pharma, Inc. (BBIO)Blueprint Medicines Corporation (BPMC)
Which stock do you think will perform better?
BridgeBio Pharma, Inc.
BBIO
Blueprint Medicines Corporation
BPMC
| Metric | BridgeBio Pharma, Inc. (BBIO) | Blueprint Medicines Corporation (BPMC) |
|---|---|---|
| Current Price | $46.85 | $129.46 |
| Change | 0.11 (0.24%) | 0.00 (0.00%) |
| Market Cap | $8.90B | $8.37B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -15.31 | -137.72 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $48.68 | $129.55 |
| 52-Week Low | $21.72 | $73.04 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-3.56 | $-2.51 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| BBIO | 12.27% | 29.85% | 78.89% | 47.65% | 70.05% | 70.05% |
| BPMC | 0.98% | 15.63% | 12.60% | 65.06% | 308.26% | 308.26% |